In every pharma operation, the basic backbone for quality depends on the quality levels of the research and development facility. Rakshit Pharma is indeed fortunately to have at its helm a highly experienced and eminent leader like Mr. Rameshwara Rao, who has over 25 years of in depth and rich experience in major pharma companies. He leads a well qualified and talented R & D team composed of 6-8 people, chemists, analytical chemists and process professionals who monitor the quality parameters of each batch of production. The world-class facilities available at the R & D lab signify the importance we give to research at Rakshit Pharma.

The process of research and development is laid down on sound lines as per internationally accepted standards. The R & D effort at Rakshit Pharma include innovative research on new products and processes of interest to the health care industry.

Our R&D facility and infrastructure is organized around three focus areas:

* Generics drug master files (DMFs) for APIs and abbreviated new drug applications (ANDAs) for finished products
* New chemical entities (NCE) using the synthetic and routes
* Novel drug delivery systems (NDDS)